Onderneming Alliqua Biomedical Inc Nasdaq
Aandelen
US0196212007
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 01-10-07 |
Rick Orr
CEO | Chief Executive Officer | - | 01-12-10 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 01-01-10 |
William Martin
PRN | Corporate Officer/Principal | - | 01-01-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 01-01-08 |
Dennis Podlesak
CHM | Chairman | 66 | - |
Rick Orr
CEO | Chief Executive Officer | - | 01-12-10 |
Matthew Ruth
BRD | Director/Board Member | - | 06-05-19 |
Julien Mamet
FOU | Founder | - | 01-10-07 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 807 877 | 5 807 877 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Adynxx, Inc.
100 Pine Street Suite 500
94111, San Francisco
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,18 mld. | |
+1,00% | 42,11 mld. | |
+50,47% | 40,37 mld. | |
-5,26% | 28,85 mld. | |
+13,68% | 26,09 mld. | |
-22,99% | 18,71 mld. | |
+8,22% | 13,26 mld. | |
+32,41% | 12,32 mld. | |
-1,62% | 11,99 mld. |